The effects of retinoids on cell differentiation and proliferation, as
well as on the inflammatory process, have been well documented, but s
o far their clinical use has been affected by teratogenicity and hyper
vitaminosis A [Loeliger, Bollag & Maier (1980). Eur. J. Med. 15, 9-151
. The need for safer drugs led to the synthesis of new oxaretinoids. T
he title compound, (2E,4E,6E)-ethyl methyl-2H-1-benzopyran-3-yl)hepta-
2,4,6-trienoate, C]9H20O3, is an oxaretinoid resulting from the integr
ation of the fourth double bond of retinoic acid into a pyran ring. Th
e structural analogy with retinoic acid is reinforced by the similar d
istances found between the geometrical centre of the rings and the 0 a
tom of the carbonyl group.